ERBB2 and ovarian carcinoma: Some studies report that other receptors in the HER family are expressed in ovarian cancer and this opens the possibility that the activity of HER2 in ovarian cancer is more complex suggesting that formation of heterodimeric HER2/HERx receptors could facilitate HER2 oncogenic activity even in the absence of HER2 amplification (13, 24, 25).